(Q48032039)

7 February 2018

title

A semiautomated measure of whole-brain atrophy in multiple sclerosis. (English)

1 reference

7 February 2018

0 references

Robert A Bermel

1

1 reference

7 February 2018

Jitendra Sharma

2

1 reference

7 February 2018

Christopher W Tjoa

3

1 reference

7 February 2018

Srinivas R Puli

4

1 reference

7 February 2018

Rohit Bakshi

5

1 reference

7 February 2018

publication date

1 April 2003

1 reference

7 February 2018

Journal of the Neurological Sciences

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

7 February 2018

volume

208

1 reference

7 February 2018

issue

1-2

1 reference

7 February 2018

page(s)

57-65

1 reference

7 February 2018

Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Axonal transection in the lesions of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Magnetic resonance imaging of multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Thalamic neurodegeneration in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Brain MRI lesions and atrophy are related to depression in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Eight-year follow-up study of brain atrophy in patients with MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Detection of ventricular enlargement in patients at the earliest clinical stage of MS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Defining the clinical course of multiple sclerosis: Results of an international survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Whole brain volume changes in patients with progressive MS treated with cladribine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Ventricular enlargement in multiple sclerosis: a comparison of three-dimensional and linear MRI estimates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

A Wallerian degeneration pattern in patients at risk for MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Iron and oxygen radicals in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

Brain iron transport and neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900425-2

10.1016/S0022-510X(02)00425-2

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018